Table III.
Recommended Tier II Drugs/Drug Classes
| DRE category; cannabis | |
| Synthetic cannabinoids | |
| DRE category; CNS stimulants | |
| Cathinones | |
| Methylphenidate | |
| Mitragynine | |
| DRE category; CNS depressants | |
| Atypical antipsychotics | |
| Barbiturates | |
| Carbamazepine | |
| Chlordiazepoxide | |
| Chlorpheniramine | |
| Cyclobenzaprine | |
| Diphenhydramine | |
| Doxylamine | |
| Gabapentin | |
| Gamma-hydroxybutyrate | |
| Hydroxyzine | |
| Lamotrigine | |
| Mirtazapine | |
| Novel benzodiazepines | |
| Phenytoin | |
| Pregabalin | |
| Secobarbital | |
| Topiramate | |
| Trazodone | |
| Tricyclic antidepressants | |
| Valproic acid | |
| Zopiclone | |
| DRE category; narcotic analgesics | |
| Fentanyl analogs | |
| Novel opioids | |
| Tapentadol | |
| DRE category; dissociative drugs | |
| Dextromethorphan | |
| Ketamine | |
| PCP | |
| DRE category; inhalants | |
| Difluoroethane | |
| Inhalant class | |
| DRE category; hallucinogens | |
| Hallucinogens |